跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,921 条关于
“Zai Lab Limited”
全部
19,921
临床试验
6,043
药物
522
机构
1,831
资讯
11,525
去年
Zai Lab Reports Strong Q3 2024 Growth, Highlights Pipeline Advances Including KarXT and ZL-1310
去年
Zai Lab's Augtyro Included in China's National Reimbursement Drug List for ROS1+ NSCLC
去年
Zai Lab's KarXT Shows Positive Phase 3 Results for Schizophrenia Treatment in China
去年
Zai Lab's KarXT Shows Positive Phase 3 Results in China for Schizophrenia
9个月前
Zai Lab Secures Reimbursement Renewal for Three Key Therapies in China's 2025 National Drug List
3个月前
Zai Lab Secures China NMPA Approval for TIVDAK, First ADC for Recurrent or Metastatic Cervical Cancer
去年
Zai Lab to Present Phase 1 Data on Novel DLL3-Targeted ADC for Small Cell Lung Cancer at ASCO 2025
11个月前
Zai Lab's DLL3-Targeted ADC Zocilurtatug Pelitecan Shows Promise in Phase 1 Small Cell Lung Cancer Trial
11个月前
Revolution Medicines Appoints Alan Sandler as Chief Development Officer to Advance RAS-Targeted Cancer Pipeline
去年
Tisotumab Vedotin Demonstrates Survival Benefit in Chinese Cervical Cancer Subpopulation
第 1 页,共 1153 页
上一页
下一页